Summary of the National Advisory Committee on Immunization (NACI) rapid response: Updated guidance on the use of Imvamune® for the prevention of mpox
Joshua Montroy, Marina Salvadori, Nicole Forbes, Kristin Klein · 2026
Read Summary of the National Advisory Committee on Immunization (NACI) rapid response: Updated guidance on the use of Imvamune® for the prevention of mpox by Joshua Montroy, Marina Salvadori, Nicole Forbes, Kristin Klein (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13262619.txt.
Description
Canada's vaccine advisory body updated its mpox guidance after a new virus subclade changed the picture. Joshua Montroy, Marina Salvadori, Nicole Forbes, and Kristin Klein summarize the rapid response in 2026. The committee reviewed current mpox spread in Canada and abroad, vaccine coverage, and studies on the vaccine's safety and effect, weighing ethics, equity, and practicality as well.
Beyond the high-risk groups named earlier, the committee now advises the vaccine for certain travelers heading to areas with ongoing community spread of the new clade. Health workers traveling to support outbreak response should also get it. Domestic health workers with frequent high-risk exposure may consider it case by case. Travel advice was built with Canada's tropical medicine committee.
Catalog record
| CREATOR | Joshua Montroy, Marina Salvadori, Nicole Forbes, Kristin Klein |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |